Major Depressive Disorder

>

On the HCPLive Major Depressive Disorder condition center page, resources on the topics of medical news and expert insight into depression can be found. Content includes articles, interviews, videos, podcasts, and breaking news on MDD research, treatment, and drug development.

Latest News

Credit: US Food and Drug Administration
FDA Approves Esketamine as First Monotherapy for Treatment-Resistant Depression

January 21st 2025

The FDA approved esketamine (SPRAVATO) nasal spray as the first monotherapy for adults with TRD, showing rapid efficacy at 4 weeks.

Guohua Li, MD, DrPH I Credit: Columbia, Mailman School of Public Health
6.2% of Community-Dwelling Older Adults in a Multisite Sample Face Depression

January 10th 2025

Credit: Adobe Stock/ AnnaStills
Exploratory Study Shows Promise of SP-624 for Improving Depression, Cognition

January 10th 2025

Peter Jongho Na, MD, MPH  Credit: Yale School of Medicine
Study Identifies Social Determinants of Suicide Mortality, Suicide Attempts

January 4th 2025

Rob Lenz, MD, PhD I Credit: Neumora
Phase 3 KOASTAL-1 Trial Fails to Show Navacaprant Significantly Improves MDD

January 2nd 2025

© 2025 MJH Life Sciences

All rights reserved.